Shareholders that lost money on Picard Medical, Inc.(PMI) should contact Levi & Korsinsky about pending Class Action - PMI

Core Viewpoint - A class action securities lawsuit has been filed against Picard Medical, Inc. for alleged securities fraud affecting investors between September 2, 2025, and October 31, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Picard Medical was involved in a fraudulent stock promotion scheme that utilized social media misinformation and impersonation of financial professionals [2]. - It is alleged that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [2]. - The complaint states that Picard's public statements and risk disclosures failed to mention the false rumors and artificial trading activity that influenced the stock price [2]. - As a result of these actions, the defendants' positive statements regarding the Company's business and prospects were misleading and lacked a reasonable basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses in Picard Medical during the specified timeframe have until April 3, 2026, to request to be appointed as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].